uniam Secures Series A Funding to Advance Cat Healthcare
uniam, a Japan-based company dedicated to enhancing the health and lifespan of cats through veterinary-based products, has successfully raised ¥770 million in its Series A funding round. The funding was led by WPower Fund, with additional participation from ANOBAKA and Crest Skill Partners.
Focus on Cat Healthcare
Founded by Ai Sugimoto, uniam focuses on providing evidence-based cat food and care products. The company’s mission centers around extending the healthy lifespan of cats by offering scientifically-backed nutritional options. Since launching its product line in February 2023, uniam has introduced 30 different items, available through various premium retail channels including Roppongi Midtown, Matsuya Ginza, and 190 Aeon Pet stores across Japan.
Strategic Use of Funds
The newly acquired funds will be instrumental in several key areas. uniam plans to leverage the investment to boost marketing and business development efforts, enhance recruitment for research and development, and strengthen its wholesale sales strategy. Additionally, the company aims to expand its product development initiatives through joint research projects with academic institutions.
Research and Development Initiatives
uniam is set to establish the "uniam Longevity Lab" in March 2026, which will spearhead long-term research and development activities. The company is collaborating with Miyagi University and the Graduate School of Agricultural Science at Tohoku University to apply findings from studies on gut health, metabolism, and aging markers to their product development. This research could potentially extend into drug discovery, aligning with uniam's broader vision for innovation in cat healthcare.
Market Expansion and Growth
The Series A funding will also support uniam's plans to expand its distribution network, ensuring broader access to their products. With reported growth in monthly sales by up to 100 times since their product launch, the company is poised to further cement its footprint in the pet healthcare market.
Ai Sugimoto, founder and CEO, commented on the funding, emphasizing the company's commitment to advancing veterinary science in the service of cat health. "We are dedicated to providing cats with the best possible care through scientifically validated products," Sugimoto stated.
uniam's latest funding round represents a significant step towards achieving its mission of enhancing the quality of life for cats through innovative healthcare solutions.